Full Text View
Tabular View
No Study Results Posted
Related Studies
Glutaminergic Agents for Cocaine Abuse - 5
This study has been completed.
Study NCT00000280   Information provided by National Institute on Drug Abuse (NIDA)
First Received: September 20, 1999   Last Updated: June 23, 2005   History of Changes

September 20, 1999
June 23, 2005
 
 
Cocaine effects
Same as current
Complete list of historical versions of study NCT00000280 on ClinicalTrials.gov Archive Site
 
 
 
Glutaminergic Agents for Cocaine Abuse - 5
Glutaminergic Agents for Cocaine Abuse

The purpose of this study is to evaluate glutaminergic agents for cocaine abuse.

 
Phase I
Interventional
Treatment
Cocaine-Related Disorders
Drug: Nimodipine
 
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Completed
0
 
 

Please contact site for information.

Both
18 Years to 45 Years
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00000280
 
NIDA-09250-5, P50-09250-5
National Institute on Drug Abuse (NIDA)
VA Connecticut Healthcare System
Principal Investigator: Thomas R Kosten, M.D. VA Connecticut Healthcare System
National Institute on Drug Abuse (NIDA)
December 2002

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP